Te‐Chun Hsia
China Medical University · 296 works · 7,558 citations · h-index 29
Top works
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
- Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.
- Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
- Gallic Acid Induces Apoptosis via Caspase-3 and Mitochondrion-Dependent Pathways in Vitro and Suppresses Lung Xenograft Tumor Growth in Vivo
- Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
- Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study
- Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
- Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
- Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer
- Baicalein induced in vitro apoptosis undergo caspases activity in human promyelocytic leukemia HL-60 cells
- Central retinal artery occlusion and brain infarctions after nasal filler injection
- Risk of Periodontal Diseases in Patients With Chronic Obstructive Pulmonary Disease
- Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)‐mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase‐3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U‐2 OS cells
- Risk of Periodontal Disease in Patients With Asthma: A Nationwide Population‐Based Retrospective Cohort Study
- A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
- The effects of body mass index on spirometry tests among adults in Xi’an, China
- Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters